MVP vs NOX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

NOX

NOXOPHARM FPO [NOX]

55MEDIUM

Score Breakdown

MVP NOX
Technical
37
46
Catalyst
54
50
Sentiment
50
50
Fundamental
95
39
Momentum
49
60
Risk Gate
50
46

Key Metrics

MVP Metric NOX
$45.6MMarket Cap$26.1M
136KAvg Volume (20d)168K
N/AShort InterestN/A
$0.76552-Week High$0.135
$0.36552-Week Low$0.046
+0.0%Daily Change+4.7%
$0.405Reference Price$0.089
-0.8%ROE-343.6%
-1.1%Profit Margin-161.7%

Active Signals

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

NOX Signals

●MACD momentum is losing steam
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Drifting lower — down 6.8% over the last 5 days
●Beating the Small Ords index — relative strength of 1.26, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.1 quarters)
●Moderate P/S ratio (7.7x)
●Strong revenue growth (+50%)

Ask Scout AI to compare MVP and NOX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MVP vs NTI →MVP vs PAR →MVP vs PIQ →MVP vs SPL →MYX vs NSB →
MVP Full Analysis → NOX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).